Correlation Between Summit Therapeutics and Mainz Biomed

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Mainz Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Mainz Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Mainz Biomed BV, you can compare the effects of market volatilities on Summit Therapeutics and Mainz Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Mainz Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Mainz Biomed.

Diversification Opportunities for Summit Therapeutics and Mainz Biomed

0.09

Correlation Coefficient

Summit Therapeutics  Mainz Biomed

Significant diversification

The 3 months correlation between Summit and Mainz is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Mainz Biomed BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mainz Biomed BV and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Mainz Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mainz Biomed BV has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Mainz Biomed go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Mainz Biomed

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 0.7 times more return on investment than Mainz Biomed. However, Summit Therapeutics PLC is 1.43 times less risky than Mainz Biomed. It trades about 0.07 of its potential returns per unit of risk. Mainz Biomed BV is currently generating about -0.01 per unit of risk. If you would invest  1,789  in Summit Therapeutics PLC on December 28, 2024 and sell it today you would earn a total of  243.00  from holding Summit Therapeutics PLC or generate 13.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Mainz Biomed BV

Summit Therapeutics PLC

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Mainz Biomed BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mainz Biomed BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Summit Therapeutics and Mainz Biomed

The main advantage of trading using opposite Summit Therapeutics and Mainz Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Mainz Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mainz Biomed will offset losses from the drop in Mainz Biomed's long position.

The idea behind Summit Therapeutics PLC and Mainz Biomed BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.